[1] W E Müller, et al. On the neuropharmacology of harmane and other beta-carbolines. Pharmacol Biochem Behav. 1981 May;14(5):693-9. DOI:
10.1016/0091-3057(81)90133-7[2] Musgrave IF, et, al. Harmane produces hypotension following microinjection into the RVLM: possible role of I(1)-imidazoline receptors. Br J Pharmacol. 2000 Mar;129(6):1057-9. DOI:
10.1038/sj.bjp.0703142[3] Glover V, et, al. β-Carbolines as selective monoamine oxidase inhibitors:In vivo implications DOI:
10.1007/BF01254930[4] https://pubmed.ncbi.nlm.nih.gov/345280/
[5] E D Louis, et al. Harmane induces anxiolysis and antidepressant-like effects in rats. Ann N Y Acad Sci. 2005 Aug 9;65(3):391-6. DOI:
10.1196/annals.1304.024[6] Yoo Jung Yang, et al. Effects of harman and norharman on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells. Eur J Pharmacol. 2008 Jun 10;587(1-3):57-64. DOI:
10.1016/j.ejphar.2008.03.050